BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pan D, Liu HN, Qu PF, Ma X, Ma LY, Chen XX, Wang YQ, Qin XB, Han ZX. Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy. World J Gastrointest Oncol 2024; 16(2): 273-286 [PMID: 38425407 DOI: 10.4251/wjgo.v16.i2.273]
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/273.htm
Number Citing Articles
1
JieYu Li, WanSong Lin, TianYing Huang, MingShui Chen, QiaoYan Lin. IL-12 improves the anti-HCC efficacy of dendritic cells loaded with exosomes from overexpressing Rab27a tumor cellsExperimental Cell Research 2024; 439(1): 114073 doi: 10.1016/j.yexcr.2024.114073
2
Pranav Kumar, Chase J. Wehrle, Keyue Sun, Chunbao Jiao, Rebecca Panconesi, Mingyi Zhang, Noah X. Tocci, Hanna Hong, Abby Gross, Erlind Allkushi, Maureen Whitsett Linganna, Andrea Schlegel, Toms Augustin, Charles Miller, David CH Kwon, Kazunari Sasaki, Federico Aucejo. Combining liver-directed and immunotherapy in advanced hepatocellular carcinoma: A review and future directionsSurgical Oncology Insight 2024; 1(4): 100100 doi: 10.1016/j.soi.2024.100100
3
Yamei Huang, Min Peng, Weiping Yu, Hui Li. Activation of Wnt/β-catenin signaling promotes immune evasion via the β-catenin/IKZF1/CCL5 axis in hepatocellular carcinomaInternational Immunopharmacology 2024; 138: 112534 doi: 10.1016/j.intimp.2024.112534
4
Jiuliang Jiang, Pingping Yang, Xinyu Xu, Huixiong Yuan, Haitao Zhu. Donafenib inhibits PARP1 expression and induces DNA damage, in combination with PARP1 inhibitors promotes apoptosis in liver cancer cellsAnti-Cancer Drugs 2024; 35(9): 789 doi: 10.1097/CAD.0000000000001631
5
Sung Hoon Choi, Do Young Kim. Regulation of Tumor Microenvironment through YAP/TAZ under Tumor HypoxiaCancers 2024; 16(17): 3030 doi: 10.3390/cancers16173030